Jacobs Levy Equity Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-535,836
| Closed | -$1.59M | – | 1121 |
|
|
2022
Q1 | $1.59M | Buy |
535,836
+286,767
| +115% | +$851K | 0.01% | 670 |
|
|
2021
Q4 | $1.12M | Buy |
249,069
+232,884
| +1,439% | +$1.05M | 0.01% | 722 |
|
|
2021
Q3 | $79K | Buy |
+16,185
| New | +$79K | ﹤0.01% | 1016 |
|
|
2021
Q2 | – | Sell |
-63,210
| Closed | -$446K | – | 1140 |
|
|
2021
Q1 | $446K | Buy |
63,210
+26,220
| +71% | +$185K | ﹤0.01% | 873 |
|
|
2020
Q4 | $232K | Buy |
+36,990
| New | +$232K | ﹤0.01% | 952 |
|
|
2018
Q3 | – | Sell |
-48,900
| Closed | -$499K | – | 1098 |
|
|
2018
Q2 | $499K | Buy |
48,900
+6,070
| +14% | +$61.9K | 0.01% | 797 |
|
|
2018
Q1 | $557K | Buy |
42,830
+30,100
| +236% | +$391K | 0.01% | 764 |
|
|
2017
Q4 | $228K | Buy |
+12,730
| New | +$228K | ﹤0.01% | 881 |
|